Generation of conditional Acvrl1 knockout mice by CRISPR/Cas9-mediated gene targeting
Authors:
- 1 February 2018
- journal article
- research article
- Published by Elsevier in Molecular and Cellular Probes
- Vol. 37, 32-38
Abstract
No abstract availableKeywords
Funding Information
- Shanghai Municipal Science and Technology Commission (15411952200)
- Shanghai Municipal Science and Technology Commission (16140903100)
This publication has 24 references indexed in Scilit:
- Endoglin and alk1 as therapeutic targets for hereditary hemorrhagic telangiectasiaExpert Opinion on Therapeutic Targets, 2017
- Animal Models in Studying Cerebral Arteriovenous MalformationBioMed Research International, 2015
- De Novo Cerebrovascular Malformation in the Adult Mouse After Endothelial Alk1 Deletion and Angiogenic StimulationStroke, 2014
- Medical management with or without interventional therapy for unruptured brain arteriovenous malformations (ARUBA): a multicentre, non-blinded, randomised trialThe Lancet, 2014
- Age-Dependent Lethality in Novel Transgenic Mouse Models of Central Nervous System Arteriovenous MalformationsStroke, 2012
- Hereditary hemorrhagic telangiectasia: An overview of diagnosis, management, and pathogenesisGenetics in Medicine, 2011
- Arteriovenous malformation in the adult mouse brain resembling the human diseaseAnnals of Neurology, 2010
- Diagnosis and Management of Arteriovenous Malformations in ChildrenNeurosurgery Clinics of North America, 2010
- ALK5- and TGFBR2-independent role of ALK1 in the pathogenesis of hereditary hemorrhagic telangiectasia type 2Blood, 2008
- Arteriovenous malformations in mice lacking activin receptor-like kinase-1Nature Genetics, 2000